EP 2167078 A2 20100331 - USE OF PACTIMIBE FOR THE PREPARATION OF A DRUG INTENDED TO PREVENT OR TREAT A DISEASE CAUSED BY A SEBACEOUS GLAND DYSFUNCTION IN HUMANS OR ANIMALS
Title (en)
USE OF PACTIMIBE FOR THE PREPARATION OF A DRUG INTENDED TO PREVENT OR TREAT A DISEASE CAUSED BY A SEBACEOUS GLAND DYSFUNCTION IN HUMANS OR ANIMALS
Title (de)
VERWENDUNG VON PACTIMIBE ZUR HERSTELLUNG EINES MEDIKAMENTS ZUR VORBEUGUNG ODER BEHANDLUNG EINER DURCH TALGDRÜSENDYSFUNKTION HERBEIGEFÜHRTEN KRANKHEIT BEI TIEREN ODER MENSCHEN
Title (fr)
UTILISATION DU PACTIMIBE POUR LA PRÉPARATION D'UN MÉDICAMENT DESTINÉ À PRÉVENIR OU À TRAITER UNE MALADIE DUE À UN DYSFONCTIONNEMENT DES GLANDES SÉBACÉES CHEZ L'HOMME OU L'ANIMAL
Publication
Application
Priority
- FR 2008051345 W 20080717
- FR 0756602 A 20070719
Abstract (en)
[origin: WO2009013433A2] The invention relates to the use of at least one compound selected from among N-(1-octyl-5-carboxymethyl-4,6-dimethylindolin-7-yl)-2,2-dimethylpropanamide (pactimibe) having formula (I), the pharmaceutically acceptable salts thereof and the pharmaceutically acceptable solvates of same, for the preparation of a drug intended to prevent or treat a disorder caused by a sebaceous gland dysfunction in humans or animals, such as acne and/or any condition or disorder linked to an overproduction of sebum, for example seborrheic dermatitis, oily skin or oily scalp.
IPC 8 full level
A61K 31/405 (2006.01); A61K 31/404 (2006.01); A61P 17/08 (2006.01); A61P 17/10 (2006.01)
CPC (source: EP US)
A61K 31/405 (2013.01 - EP US); A61P 17/08 (2017.12 - EP); A61P 17/10 (2017.12 - EP)
Citation (search report)
See references of WO 2009013433A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA MK RS
DOCDB simple family (publication)
FR 2918890 A1 20090123; CA 2692842 A1 20090129; EP 2167078 A2 20100331; US 2010179209 A1 20100715; WO 2009013433 A2 20090129; WO 2009013433 A3 20090326
DOCDB simple family (application)
FR 0756602 A 20070719; CA 2692842 A 20080717; EP 08826558 A 20080717; FR 2008051345 W 20080717; US 68831010 A 20100115